Skip to main content

Table 6 Impact of 18FDG-PET/CT on treatment management

From: Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience

n

%

Decision without 18FDG-PET/CT

Decision with 18FDG-PET/CT

2

4.6

Therapeutic dose of 131I only

Another neck dissection prior to 131I therapy

7

16.2

Therapeutic dose of 131I only

External radiation to symptomatic bone recurrences after 131I therapy

6

13.9

Therapeutic dose of 131I 5.5 GBq

Enhancement of the dose to 7.5 GBq

1

2.3

Therapeutic dose of 131I only

*Surgical excision of the large hepatic recurrence pre I 131therapeutic dose

2

4.6

Therapeutic dose of 131I only

*Surgical excision of thyroid recurrence before 131I therapy

Sum

  

18

41.6

20

46.5

Only therapeutic dose of 131I

Only therapeutic dose of 131I

5

11.6

Therapeutic dose of 131I followed by external radiation

Therapeutic dose of 131I followed by external radiation

Sum

  

43

100

  1. *Patients did not undergo surgical excision